Both diseases are characterized by the accumulation of neurotoxic protein depositions, consisting of TAR DNA binding protein (TDP-43) in > 95% of ALS cases and about 50% of FTLD cases [2, 3]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.